Guiding Your Radiopharmaceuticals Journey
Unlock growth in radiopharmaceutical healthcare with expert consulting and thought leadership. Shaemus Gleason provides specialized insights on clinical trials and commercialization to help radiopharm businesses thrive in a complex market.
Navigating Industry Complexities
The radiopharmaceutical landscape poses unique challenges: from targeted radionuclide therapies to PET and SPECT imaging. Navigate obstacles businesses face in this specialized field and how to effectively address them.
Regulatory Challenges
Navigating an intricate regulatory environment can be daunting. Businesses often struggle to comply with compliance requirements, risking project delays and increased costs without expert guidance.
Market Analysis & Investment
Interest in this blossoming sector is driving investment. Companies need strategic market insights to differentiate, avoid potential pitfalls and seize growth opportunities before the competition.
Operational Inefficiencies
Many organizations face operational hurdles that impede their productivity. Addressing inefficiencies in drug manufacturing and supply chain processes is crucial for sustainable growth.
Shaemus Gleason started in the space in 2008 and has pioneered commercial, clinical, and operational strategies for diagnostic and therapeutic radiopharmaceutical companies ever since.
His work in the radiopharmaceutical industry has recently focused on alpha and beta-based therapies as well as stand-alone and companion diagnostics. He has worked across the entire spectrum of drug development and associated execution from Phase 0 to Phase 4. This experience also extends to isotope selection, drug product manufacturing, commercial strategy, operational execution, business development and licensing. Having supported a range of companies, from pre-IPO biotech startups to Fortune 19 corporations, he brings a unique perspective to the field. This diverse background allows for big picture insights and guided consideration of the unique interdependencies between drug development, manufacturing, and market growth in this highly specialized industry.
Radio-Isotope Solutions
Shaemus Gleason is available for bespoke consulting services, board seat or strategic advisory roles, due diligence support and PR engagements. He helps peers, emerging businesses, private equity and financial institutions to tackle industry-specific challenges. Shaemus empowers businesses with strategic insights and operational excellence to improve the adoption of radiopharmaceutical solutions, ultimately helping improve patient outcomes.
Strategic Guidance
- Tailored consulting for radiopharmaceuticals
- Operations and commercialization
- Deep expertise from 18 years in the space
Executive Advisory
- Board membership & executive level advisory
- Equipping emerging or established businesses
- Actionable insights for decision-making
Thought Leadership
- Frequent conference presenter, podcaster, and subject matter expert
- Pro-bono guidance for non-profits
- Expert knowledge in a niche, evolving space
“The expertise Shaemus brings to the table is unmatched. We call him the mayor of radiopharmville.”
Dr. Luke Norquist
CEO & Urologic Medical Oncologist of the Urology Cancer Center & GU Research Network,
Urologic Medical Oncologist for Memorial Sloan Kettering Cancer Center
Let’s chat partnership!
Taking requests for relevant consulting, boards, and PR opportunities
Shaemus Gleason: RadioPharm Advisory 